Alliance Pharma has reported a 28% increase in pre-tax profit of £28.4m ($40m) for the year ending December 2017, while revenue rose 6% to 24. The company also said underlying pre-tax profit rose 8% to ££103.3mm, and despite spending spending £16m on acquisitions, net debt was reduced to £72.3m from the 2016 figure of £76.1m.
Alliance Pharma has reported a 28% increase in pre-tax profit of £28.4m ($40m) for the year ending December 2017, while revenue rose 6% to £103.3m. The company also said underlying pre-tax profit rose 8% to £24m, and despite spending spending £16m on acquisitions, net debt was reduced to £72.3m from the 2016 figure of £76.1m.